Filing Details
- Accession Number:
- 0001570523-18-000019
- Form Type:
- 5
- Zero Holdings:
- No
- Publication Time:
- 2018-03-30 16:57:19
- Reporting Period:
- 2017-12-31
- Accepted Time:
- 2018-03-30 16:57:19
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1559356 | Immune Therapeutics Inc. | IMUN | Pharmaceutical Preparations (2834) | 593226705 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1570523 | Jackman Robert Dailey | 401 First Street Los Altos CA 94022 | No | No | No | Yes |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-09-27 | 10,000 | $0.10 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-09-27 | 10,000 | $0.11 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-09-27 | 10,000 | $0.11 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-09-28 | 5,000 | $0.10 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-09-28 | 1,000 | $0.10 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-10-03 | 10,000 | $0.09 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-10-04 | 21,400 | $0.09 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-10-04 | 3,600 | $0.06 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-10-04 | 30,000 | $0.08 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-10-18 | 1,000 | $0.08 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-10-24 | 1,250 | $0.07 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-10-24 | 18,750 | $0.08 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-10-24 | 20,000 | $0.08 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-10-25 | 1,250 | $0.07 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-10-25 | 1,250 | $0.07 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-10-25 | 1,250 | $0.07 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-10-25 | 14,200 | $0.08 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-10-25 | 2,050 | $0.08 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-10-27 | 15,000 | $0.07 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-10-31 | 10,000 | $0.07 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-11-02 | 1,250 | $0.07 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-11-02 | 3,750 | $0.07 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-11-03 | 5,000 | $0.08 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-11-07 | 1,100 | $0.08 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-11-14 | 1,000 | $0.06 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-11-15 | 15,000 | $0.07 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-11-16 | 1,000 | $0.08 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-11-17 | 1,000 | $0.08 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-11-21 | 1,000 | $0.06 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-11-21 | 500 | $0.06 | 20,800,359 | No | 5 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct |
Billionaire Hedge Funds
